When must, when should, when can ACE inhibitors be administered in heart failure?
Jahrmärker, H.
Medizinische Klinik 88(8): 496-502
1993
ISSN/ISBN: 0723-5003 PMID: 8413052 Document Number: 414051
Document emailed within 1 workday
Related Documents
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108McMurray, J.J. 1998: Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? European Heart Journal 19(Suppl): L15-L21
1994: ACE inhibitors and kidney failure in heart failure Giornale Italiano di Cardiologia 24(5): 645-648
2001: Beta blockers in heart failure administered with too much reticence. Longevity sacrificed MMW Fortschritte der Medizin 143(48): 60
Held, P.; Swedberg, K. 1990: ACE inhibitors in the treatment of heart failure Nordisk Medicin 105(8-9): 217-218
Shen, H.; Ai, Q.-H.; Xie, Y.-M.; Hao, Y.; Hu, J.; Zhang, Y.-L. 2013: Parenterally administered shenqi fuzheng for heart failure: a systematic review and meta-analysis Zhongguo Zhong Yao Za Zhi 38(18): 3200-3208
Komajda, M. 1999: ACE inhibitors in heart failure: the question of dose International Journal of Clinical Practice. Supplement 100: 12-14
Reid, J. 1993: Are ACE inhibitors equal in congestive heart failure? South African Medical Journal: 1-3
Widimský, J.ří 2015: The new drug is much more effective than ACE inhibitors in chronic heart failure Vnitrni Lekarstvi 61(2): 129-133
Trindade, P.T.; Rouleau, J.L. 2001: Vasopeptidase inhibitors: potential role in the treatment of heart failure Heart Failure Monitor 2(1): 2-7
Hofman-Bang, C.; Rydén, L.; Ponikowski, P. 1991: Mortality studies in heart failure. the role of ACE inhibitors becomes more important Lakartidningen 88(51-52): 4407-4409
Mitrovic, V.; Mudra, H.; Bonzel, T.; Schmidt, W.; Schlepper, M. 1996: Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure Zeitschrift für Kardiologie 85(11): 828-838
Zannad, F. 1992: Management of the treatment with converting enzyme inhibitors in chronic heart failure La Revue du Praticien 42(20): 2563-2567
Arslanagić, A.; Raljević, E. 1999: Converting enzyme inhibitors in acute myocardial infarct and heart failure Medicinski Arhiv 53(1): 29-31
Ikram, H.; Nicholls, M.G.; Fitzpatrick, M.A.; Crozier, I.G. 1986: ACE inhibitors or inotropic drugs after diuretics in heart failure--a personal critique Postgraduate Medical Journal 62(Suppl 1): 176-178
Guazzi, M.D.; Berti, M.; Dardani, M.; Muratori, E.; Guazzi, M. 1989: Two sides of the coin, or converting enzyme inhibitors in the therapy of heart failure Cardiologia 34(1): 15-18
Sami, M.H. 1994: Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure Canadian Journal of Cardiology 10 Suppl D: 13d-16d
Kolber-Postepska, B. 1992: Treatment of chronic congestive heart failure using angiotensin converting enzyme inhibitors Wiadomosci Lekarskie 45(23-24): 903-906
Simko, F.; Riecanský, I. 1996: ACE-inhibitors in the treatment of chronic heart failure: pathophysiologic principles of protective effects Bratislavske Lekarske Listy 97(10): 583-586
Thilly, N.; Zannad, Fïez.; Dufay, E.; Juillière, Y.; Briançon, S. 2003: Angiotensin-converting enzyme inhibitors in congestive heart failure: clinical practice guidelines Therapie 58(4): 341-349